Freedom Pharmaceutical Pty Ltd v Minister for Health

Link copied
Case Copied 27 min read

FEDERAL COURT OF AUSTRALIA

Freedom Pharmaceutical Pty Ltd v Minister for Health [2022] FCAFC 123

Appeal from: Freedom Pharmaceutical Pty Ltd v Minister for Health [2021] FCA 213
File number: NSD 413 of 2021
Judgment of: MARKOVIC, THOMAS AND STEWART JJ
Date of judgment: 20 July 2022
Catchwords: ADMINISTRATIVE LAW – appeal from a single judge of the Federal Court of Australia – where primary judge dismissed an application for judicial review of a decision of the Minister made pursuant to s 90A of the National Health Act 1953 (Cth) granting approval to a premises to supply pharmaceutical benefits – where Minister notified the appellant of the request for exercise of discretion and invited comments – whether primary judge erred in holding that notification without further details of the application was sufficient – where Minister concluded that a “community” would be left without “reasonable access” to pharmaceutical benefits if the approval were not granted – where premises in respect of which approval was granted is located approximately 60m from appellant’s pharmacy – whether primary judge erred in construing the scope of the Minister’s discretion – appeal dismissed
Legislation:

Administrative Decisions (Judicial Review) Act 1977 (Cth) s 5

Health Legislation Amendment (Pharmacy Location Arrangements) Act 2006 (Cth)

National Health Act 1953 (Cth) ss 90, 90A, 90B, 90D, 90K

National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (Cth)

Cases cited:

Djokovic v Minister for Immigration, Citizenship, Migrant Services and Multicultural Affairs [2022] FCAFC 3; 397 ALR 1

Freedom Pharmaceutical Pty Ltd v Minister for Health [2021] FCA 213

Kong v Minister for Health [2014] FCAFC 149; 227 FCR 215

Minister for Immigration and Multicultural Affairs v Eshetu [1999] HCA 21; 197 CLR 611

Pharmacy Restructuring Authority v Chatfield [1993] FCA 495; 43 FCR 418

Stambe v Minister for Health [2019] FCA 43; 270 FCR 173

Division: General Division
Registry: New South Wales
National Practice Area: Administrative and Constitutional Law and Human Rights
Number of paragraphs: 54
Date of hearing: 28 February 2022
Counsel for the Appellant: C Gunson SC and J Sawyer
Solicitor for the Appellant: Robert James Lawyers
Counsel for the Respondents: S Free SC and A Lyons
Solicitor for the Respondents: Australian Government Solicitor

ORDERS

NSD 413 of 2021
BETWEEN:

FREEDOM PHARMACEUTICAL PTY LTD

Appellant

AND:

MINISTER FOR HEALTH

First Respondent

MAGGIE ROUCHDI

Second Respondent

ORDER MADE BY:

MARKOVIC, THOMAS AND STEWART JJ

DATE OF ORDER:

20 JULY 2022

THE COURT ORDERS THAT:

1.The appeal be dismissed with costs.

Note:   Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


REASONS FOR JUDGMENT

THE COURT:

Introduction

  1. The appellant, Freedom Pharmaceutical Pty Ltd, is the operator of a pharmacy known as TerryWhite Chemmart Blacktown located in the St Martins Village shopping centre in Blacktown, New South Wales. Those premises are approved premises for the supply of pharmaceutical benefits by the appellant under s 90 of the National Health Act 1953 (Cth).

  2. The second respondent, Maggie Rouchdi, is the operator…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Freedom Pharmaceutical Pty Ltd v Minister for Health and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2022] FCAFC 123
Decision Date

CaseChat Overview and Summary

The case of Freedom Pharmaceutical Pty Ltd v Minister for Health involved a dispute over the Minister for Health's decision to grant approval for a premises to supply pharmaceutical benefits under Section 90A of the National Health Act 1953 (Cth). The appellant, Freedom Pharmaceutical, challenged the Minister's decision, arguing that the Minister had not properly considered the statutory criteria when approving the application. The case was ultimately appealed to the Federal Court of Australia, which dismissed the appeal with costs.

The primary legal issue that the court had to decide was whether the Minister had erred in his decision to grant approval for the supply of pharmaceutical benefits from the premises in question. The court had to determine whether the Minister had considered the statutory criteria when making his decision and whether the Minister had provided sufficient reasons for his decision. The court also had to consider whether the Minister had correctly interpreted the scope of his discretion under Section 90A of the Act.

In dismissing the appeal, the court held that the Minister had not erred in his decision to grant approval for the supply of pharmaceutical benefits from the premises. The court found that the Minister had properly considered the statutory criteria when making his decision and had provided sufficient reasons for his decision. The court also held that the Minister had correctly interpreted the scope of his discretion under Section 90A of the Act. The court found that the Minister was satisfied that a community would be left without reasonable access to pharmaceutical benefits if the approval were not granted and that it was in the public interest to approve the pharmacist. The court held that the Minister's decision was not Wednesbury unreasonable and was therefore valid.

The court dismissed the appeal and ordered that the appellant pay the respondent's costs. The court held that the appeal was without merit and that the Minister's decision was correctly made. The court found that the Minister had properly considered the statutory criteria and had provided sufficient reasons for his decision. The court also held that the Minister's interpretation of his discretion under Section 90A of the Act was correct. The decision of the court is a reminder of the importance of proper consideration of statutory criteria and the need for sufficient reasons to be provided for administrative decisions.

Orders

Orders of the court

1. The appeal be dismissed with costs.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

The Rules introduced in 2018 relevantly provide that in respect of a new pharmacy in a small shopping centre, it is a requirement of approval by the Secretary that the premises: (a) are in a small shopping Centre (as defined), and (b) are at least 500 m, in a straight line, from the nearest approved premises, other than approved premises in a large shopping Centre or private hospital, and (c) there are no approved premises in the small shopping Centre: Rules, Sch 1, Pt 2, item 133.Background The primary judge summarised the background to the matter, from which the following is drawn. In January 2019, Ms Rouchdi applied to the Department for approval under s 90 of the Act to supply pharmaceutical benefits from the Medical Centre premises on the basis that the premises met the requirements set out in item 133 in Pt 2 of Sch 1 of the Rules. In April 2019, the Authority wrote to advise Ms Rouchdi that it had recommended that her s 90 application not be approved on the basis that the Authority was not satisfied that the application met the requirements of item 133. Later that month, a delegate of the Secretary wrote to Ms Rouchdi advising her that, given the Authority’s recommendation, her s 90 application had been rejected. Ms Rouchdi then wrote to the Department applying under s 90B(1) of the Act for the Minister to exercise his discretionary power under s 90A(2) to approve the supply of pharmaceutical benefits at the premises notwithstanding the refusal by the Secretary. On 23 August 2019, a delegate of the Minister wrote to Ms Rouchdi to inform her that the Minister had decided to consider her s 90B application. On the same day, the delegate also wrote to Freedom, inviting submissions going to the two criteria set out in s 90A(2). Relevantly, the letter included the following:I am writing to advise you that a request has been made by a pharmacist to the Minister for Health, the Hon Greg Hunt MP (the Minister), for the exercise of the Minister's discretionary power to approve the supply of Pharmaceutical Benefits Scheme (PBS) medicines at F1, F2, F3 St Martins Crescent, Black Town Mega Centre, Blacktown NSW 2148 (the proposed premises).…Where an application is rejected because it failed to satisfy the requirements of the Rules the pharmacist may request that the Minister apply his discretionary power to approve the supply of PBS medicines from the proposed premises. The Minister may approve a pharmacist if he is satisfied that the following criteria are met:a) the decision to reject the previous application (under the Rules) will result in a community being left without reasonable access to PBS medicines supplied by an approved pharmacist; and b) it is in the public interest to approve the pharmacist.…Opportunity to comment As delegate of the Minister for Health, under subsection 90D(l)(b) of the National Health Act 1953, I invite you to submit comments, or information or documents relating to the request.If you would like to make a submission, it should be limited to the two criteria outlined earlier in this letter. …

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established